Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tocilizumab in Acute Myocardial Infarction
NCT02419937Phase 2Completed
- Sponsor
- Keesler Medical Center
- Start
- May 2015
- Primary completion
- Aug 2017
- Modality
- Antibody Conjugates, Recombinant Proteins and Enzymes, Engineered Antibody Formats
- Countries
- 1
01
Overview
A Phase 2 trial of tocilizumab in myocardial infarction (MI), sponsored by Keesler Medical Center. Started May 2015; status: completed.
02
Drugs
tocilizumab
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NCT02419937.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02419937.